fda semaglutide shortage resolved 2025 announcement Ozempic and Wegovy are no longer in shortage, says New project announcement: HHS‑OIG is

Peptide: Retatrutide 30mg Type: Longevity Brand: Bio Stem (For research purposes only) Retatrutide is known as a triple agonist, meaning it activates:GLP-1 receptors helps control appetite + slows digestionGIP receptors improves insulin response + nutrient handlingGlucagon receptors increases energy expenditure + fat burning Retatrutide is a multi-receptor agonist currently being studied for its interaction with metabolic pathways, including GLP-1, GIP, and glucagon receptors

Patients often inquire about the expected weight loss on semaglutide

Facing drug charges in Louisiana

Stressing from vasomotor symptoms of menopause

DVA rides on EPS growth and early IKC profitability, but flat treatment volumes and reimbursement risks raise questions about sustaining momentum.